Gulf starts at Sheikh Adi-2 25/05/2012
Iraq-focused oil explorer Gulf Keystone Petroleum (GKP) has begun drilling at the Sheikh Adi-2 well in the Sheikh Adi block.
ReGen Therapeutics is thought poised for new funding after announcing bullish test results for its Colostrinin Alzheimer's treatment.
AIM dog ReGen, which rekindled interest last year with test results suggesting its Zolpidem insomnia treatment could sometimes reverse some effects of severe brain damage, is now to present its latest findings on Colostrinin to the Eighth International Conference on Alzheimer's and Parkinson's Diseases at Salzburg in Austria next month. The company says an 'in vivo' study has shown Colostrinin increases the life-span and improves the neurological performance of 'inbred mice predisposed to premature ageing'.
Percy Lomax, ReGen's indefatigably cheerful executive chairman, comments 'in developing our nutraceutical product Colostrinin, we are looking to help improve people's quality of life. This study shows that, with respect to ageing and neurological functions, we may be able to do that.'
The other day Barclays Stockbrokers Gerrard emerged with six per cent of ReGen, which lost £2.2 million in 2005 and chalked up another £1.1 million deficit in the first half of last year. Shares in ReGen, floated at 20p seven years ago, have hitherto been disastrous performers, falling to 0.82p in autumn 2005 and only rallying 0.15p to 1.05p today on the latest Colostrinin findings.
The company raised £1million last July at 1p. Company watchers believe a further funding could be imminent.
Gamblers only.
Gain instant access to some of the best-performing and fastest growing companies in the small cap arenaClick here
Advertisement
Gain instant access to some of the best-performing and fastest growing companies in the small cap arena. Sign up NOW!
This unique study analyses the shareholdings of companies listed on AIM, extracting trends including rankings of the value and number of their investments.
Please click here to order your copy of the report or call 0207 250 7056.
Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.
If you're interested in business tax updates visit our specialist tax guide website.
Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.
Advertisement
Iraq-focused oil explorer Gulf Keystone Petroleum (GKP) has begun drilling at the Sheikh Adi-2 well in the Sheikh Adi block.
Oil giant Shell is extending its offer period for Mozambique-focused Cove Energy (COV) after having its bid trumped by Thai government-owned PTT Exploration & Production.
Kazakhstan-focused Roxi Petroleum (RXP) has declared that its NK7 well in the Galaz aea has drilled to a depth of 1,360 metres.
Steered by sector veteran Algy Cluff, North-Sea focused cash shell Cluff Natural Resources (CNR) has joined AIM.
Somalia-focused oil explorer Red Emperor Resources (RMP) has exercised its option to take part in the drilling of the Shabeel North well.
Oil concern Heritage Oil (HOIL) has reported its Miran West-3 well in Iraq could deliver 1,000 barrels per day of condensate.